NIST Develops Urine Standard for Accurate Kidney Disease Diagnosis
The NIST released new standard reference material that uses urine to check for kidney disease and conditions that affect kidney function.
The NIST released new standard reference material that uses urine to check for kidney disease and conditions that affect kidney function.
A new proteomic risk model for cardiovascular disease was found to be more accurate than current methods of measuring cardiac risk
Research shows that removing a race modifier from a formula used to diagnose kidney disease may lead to equitable care for Black patients.
Giving a big penalty to an algorithm for false negatives results in much better precision, UJ researchers find.
Read MoreThe National Kidney Foundation and the American Society of Nephrology have outlined a new race-free approach to diagnosing kidney disease.
Read MoreDespite their higher risk of chronic kidney disease, people with hypertension or diabetes usually are not given a protein in the urine test.
Read MoreRhabdomyolysis (rhabdo for short) is a sometimes fatal condition caused by overexertion that results in overtaxed muscle cells bursting and dying, releasing toxins into the body. Experts worry many people returning to the gym after a COVID-19 pandemic hiatus might push themselves too hard and wind up diagnosed with rhabdo, reports the Washington Post.
Read MoreResearchers from Boston University School of Medicine have developed a novel AI tool to predict the grade of IFTA for chronic kidney disease.
Read MoreA perspective article published in CJASN examines how the use of race in calculating kidney function, as well as other aspects of health, can cause harm to patients.
Read MoreThe NephroCheck test relies on the detection of two urinary biomarkers: TIMP-2 and IGFBP-7. Both are produced by stressed kidney cells before the onset of AKI.
Read MoreMultiple highly specific binders have been generated that bind to the spike proteins of SARS-CoV-2 and do not crossreact with other closely related viruses.
Read MoreThe guidance outlines scientific evidence and information on national and international standards, test methods, and specifications for fluid-resistant and impermeable gowns and coveralls used in healthcare.
Read MoreFujirebio’s latest offering is a third-generation assay that accurately measures biologically active parathyroid hormone levels resulting from disorders of calcium metabolism.
Read MoreThe National Kidney Foundation, the American Society for Clinical Pathology, and the nation’s leading laboratories and clinical laboratory associations have announced a collaboration to remove barriers to testing for chronic kidney disease.
Read MoreThe point-of-care test for the detection of infection in patients on peritoneal dialysis enables warning of infection within 10 minutes.
Read MoreThe noninvasive urine-based test for kidney rejection diagnosis utilizes metabolic biomarker networks.
Read MoreThe NGAL protein has been designed to provide a high level of purity that minimizes the risk of interferences due to contaminants.
Read MoreImmunoassay developers are staying current with new releases year round.
Read More